(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

C30H48O4 — CID 56946874

IUPAC(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
SMILESCC(C)(O)[C@H]1CCC([C@@H]2[C@@H](O)C[C@]3(C)C4=CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)[C@@H]1O
InChIInChI=1S/C30H48O4/c1-26(2)22-11-10-19-18(28(22,5)14-13-23(26)32)12-15-29(6)24(21(31)16-30(19,29)7)17-8-9-20(25(17)33)27(3,4)34/h10,17-18,20-22,24-25,31,33-34H,8-9,11-16H2,1-7H3/t17?,18-,20-,21-,22-,24+,25-,28+,29-,30+/m0/s1
InChIKeyBSMCVIBCNBLFGX-LCMRYKHQSA-N
MW472.71 g/mol
LogP5.29
Rot. Bonds2

About (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one (PubChem CID 56946874) has the molecular formula C30H48O4 and a molecular weight of 472.71 g/mol. Its IUPAC name is (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one.

Molecular Properties

Compound Name(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
PubChem CID56946874
Molecular FormulaC30H48O4
Molecular Weight472.71 g/mol
Exact Mass472.36
IUPAC Name(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
SMILESCC(C)(O)[C@H]1CCC([C@@H]2[C@@H](O)C[C@]3(C)C4=CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)[C@@H]1O
InChIInChI=1S/C30H48O4/c1-26(2)22-11-10-19-18(28(22,5)14-13-23(26)32)12-15-29(6)24(21(31)16-30(19,29)7)17-8-9-20(25(17)33)27(3,4)34/h10,17-18,20-22,24-25,31,33-34H,8-9,11-16H2,1-7H3/t17?,18-,20-,21-,22-,24+,25-,28+,29-,30+/m0/s1
InChIKeyBSMCVIBCNBLFGX-LCMRYKHQSA-N
XLogP5.29
TPSA77.76 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500472.71
LogP ≤ 55.29
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one?
The IUPAC name of (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one (CID 56946874) is (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one.
What is the SMILES notation for (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one?
The canonical SMILES for (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one is CC(C)(O)[C@H]1CCC([C@@H]2[C@@H](O)C[C@]3(C)C4=CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)[C@@H]1O.
What is the InChIKey of (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one?
The InChIKey is BSMCVIBCNBLFGX-LCMRYKHQSA-N. The full InChI is InChI=1S/C30H48O4/c1-26(2)22-11-10-19-18(28(22,5)14-13-23(26)32)12-15-29(6)24(21(31)16-30(19,29)7)17-8-9-20(25(17)33)27(3,4)34/h10,17-18,20-22,24-25,31,33-34H,8-9,11-16H2,1-7H3/t17?,18-,20-,21-,22-,24+,25-,28+,29-,30+/m0/s1.
What are the key properties of (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one?
(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one has a molecular weight of 472.71 g/mol, XLogP of 5.29, 2 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-17-[(2S,3S)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one is sourced from PubChem (CID 56946874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).